Apixaban 2.5mg – Blood Thinner for Stroke Prevention and Clot Treatment

Apixaban 2.5 mg is an oral anticoagulant (blood thinner) clinically indicated to reduce the risk of stroke and systemic embolism in patients with conditions such as non-valvular atrial fibrillation (NVAF) and to treat and prevent recurrence of blood clots including deep vein thrombosis (DVT) and pulmonary embolism (PE). Apixaban belongs to a class of medicines called factor Xa inhibitors, which reduce clot formation by blocking a key enzyme in the blood coagulation process. Apollo Pharmacy+1

Key Benefits:

• Stroke Risk Reduction: Helps lower the risk of stroke in patients with irregular heart rhythm (atrial fibrillation) by minimizing clot formation in the heart and arteries. Apollo Pharmacy

• Clot Prevention & Treatment: Effective in preventing blood clots after high-risk surgeries (e.g., hip or knee replacement) and for treating and preventing recurrences of DVT and PE. Apollo Pharmacy

• Predictable Anticoagulant Effect: Fixed-dose regimen often twice daily without the need for routine coagulation monitoring such as INR testing, unlike older blood thinners (e.g., warfarin). Biomedicus

• Convenient Oral Dosing: Taken with or without food, facilitating outpatient management. nhs.uk

Mechanism of Action:
Apixaban inhibits Factor Xa, an essential enzyme in the clotting cascade that leads to thrombin and fibrin formation. By blocking this key step, apixaban reduces the formation of blood clots and helps diminish the risk of associated complications like stroke. Apollo Pharmacy

Indications & Clinical Uses:
Apixaban 2.5 mg may be prescribed for:

• Secondary prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation who meet dose reduction criteria (e.g., elderly, low body weight, or impaired renal function). الهيئة العامة للغذاء والدواء

• Extended prevention of recurrent DVT and PE following initial treatment. Scottish Medicines Consortium

• VTE prophylaxis after orthopedic surgery (hip or knee replacement). nhs.uk
  Note: Specific dosing schedules and indications should be guided by a licensed healthcare provider.

Dosage & Administration:

• Typical Dose: Apixaban 2.5 mg tablets are commonly taken twice daily, at roughly 12-hour intervals. nhs.uk

• Duration: The length of therapy depends on the indication and clinical risk assessment. Long-term therapy may be required for chronic conditions. nhs.uk

• Administration: Swallow tablets whole with water; can be taken with or without food. nhs.uk

Safety & Precautions:

• Prescription Only: Apixaban must be used under the supervision of a qualified clinician.

• Bleeding Risk: As a blood thinner, it increases the risk of bleeding. Patients should be monitored for signs of unusual bleeding (e.g., nosebleeds, bruising, gastrointestinal bleeding). nhs.uk

• Contraindications: Active pathological bleeding and certain medical conditions (e.g., severe hepatic impairment) may preclude safe use. Medicines.org.uk

• Interaction Monitoring: Inform healthcare providers and dentists about apixaban use before procedures.

Storage:
Store tablets at room temperature away from moisture and direct light. Keep out of reach of children.